Product candidates for the treatment of excessive underarm sweating on one hand, and dry eye disease on the other, could help the two stocks highlighted in today’s article – a clinical-stage biotech company and a clinical-stage pharmaceutical company – surge by more than 100% (and potentially upwards of 500% in the case of one of the stocks), according to analysts at Oppenheimer. For more on these two stocks and their upside potential, CLICK HERE.
Product Candidates For Wet Underarms And Dry Eyes Have These 2 Stocks Dripping With Upside Potential
Tags:Biotech CompaniesBiotech StocksClinical-Stage BiotechsInvestingInvestmentsOppenheimerProduct Candidatesstock marketstocksUpside Potential